| GFACX | GQEPX | GFACX / GQEPX | |
| Total Expense Ratio | 1.35 | 0.70 | 193% |
| Annual Report Gross Expense Ratio | 1.35 | 0.71 | 190% |
| Fund Existence | 25 years | 8 years | - |
| Gain YTD | 10.104 | 8.142 | 124% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 338B | 2.75B | 12,286% |
| Annual Yield % from dividends | 0.00 | 2.21 | - |
| Returns for 1 year | 12.09 | 1.80 | 672% |
| Returns for 3 years | 44.36 | 35.61 | 125% |
| Returns for 5 years | 14.79 | 47.88 | 31% |
| Returns for 10 years | 88.17 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VOT | 304.49 | 3.03 | +1.01% |
| Vanguard Mid-Cap Growth ETF | |||
| EYLD | 47.93 | 0.28 | +0.59% |
| Cambria Emerging Shareholder Yield ETF | |||
| ZAPR | 26.61 | 0.02 | +0.08% |
| Innovator Equity Dfnd Prt ETF -1 Yr Apr | |||
| DTRE | 43.28 | N/A | N/A |
| First Trust Alerian Dsrupt Tech RE ETF | |||
| SBIO | 50.31 | -2.50 | -4.73% |
| ALPS Medical Breakthroughs ETF | |||